Hologic had two patents in internet of things during Q1 2024.Hologic Inc filed a patent for a system that involves implanting a wireless biosensor in a breast biopsy cavity to monitor biochemical parameters in real-time. The biosensor transmits data wirelessly to a surveillance system for evaluation, which can help detect trends in tumor microenvironment, monitor treatment progress, and personalize treatment plans. GlobalData’s report on Hologic gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Hologic grant share with internet of things as a theme is 50% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Wireless active monitoring implant system (Patent ID: US20240065614A1)
The patent filed by Hologic Inc. describes systems and methods for the real-time monitoring of a wireless implant, specifically a biosensor implanted in a breast biopsy cavity. The biosensor detects biochemical parameter data and transmits it wirelessly to a surveillance system for evaluation. This evaluation can involve detecting trends in a tumor's microenvironment, monitoring treatment progress, and adjusting treatment for personalized care. The method involves adjusting the set of biochemical parameters based on feedback received from anatomical measurements of the breast and monitoring the adjusted parameters to modify cancer treatment, creating a closed feedback loop to enhance treatment efficacy.
Additionally, the method includes recording, timestamping, and organizing biochemical parameters, applying data to statistical processing models to compare against baseline measurements, and identifying trends in the human body. The biosensor is visible under imaging modalities and is not bioabsorbable. The system also allows for user input of anatomical measurements, which are evaluated against the data collected by the biosensor to implement actions based on the evaluation. The method further involves data processing, trend identification, and assessment of the breast biopsy cavity to generate warnings, notifications, reports, and action items for improved patient care.
To know more about GlobalData’s detailed insights on Hologic, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.